STEMLINE THERAPEUTICS INC - COM (STML)

CUSIP: 85858C107

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
9,728,153
Share change
+781,759
Total reported value
$104,090,173
Put/Call ratio
111%
Price per share
$10.70
Number of holders
72
Value change
+$8,340,985
Number of buys
41
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 85858C107?
CUSIP 85858C107 identifies STML - STEMLINE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of STEMLINE THERAPEUTICS INC - COM (STML) as of Q4 2016

As of 31 Dec 2016, STEMLINE THERAPEUTICS INC - COM (STML) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,728,153 shares. The largest 10 holders included FMR LLC, FRANKLIN RESOURCES INC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, SABBY MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, VHCP Management II, LLC, BlackRock Institutional Trust Company, N.A., and FARALLON CAPITAL MANAGEMENT LLC. This page lists 72 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.